Evidence map›Paper›PMID 26943988›Full record

ArticleClinical breast cancer2016

Long-Term Disease-Free Survival in a Young Patient With Hormone Receptor-Positive Breast Cancer and Oligometastatic Disease in the Brain.

Poornima Saha, Andrea L Amico, Olufunmilayo I Olopade

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical breast cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Poornima SahaDepartment of Medicine, The University of Chicago, Chicago IL.
Andrea L AmicoDepartment of Medicine, The University of Chicago, Chicago IL.
Olufunmilayo I OlopadeDepartment of Medicine, The University of Chicago, Chicago IL. Electronic address: funmi.olopade@gmail.com.

Funding

Developing an Oncology Workforce for the 21st Century - Renewal 01K12CA139160 · NCI · UNIVERSITY OF CHICAGO · PI OLOPADE, OLUFUNMILAYO F., SMITH, SONALI · 2010 to 2024
$10.6M
BASIC RESEARCH TRAINING IN MEDICAL ONCOLOGYT32CA009566 · NCI · UNIVERSITY OF CHICAGO · PI OLUFUNMILAYO F. OLOPADE · 1987 to 2026
$10.5M
NCI NIH HHS K12 CA139160NCI NIH HHS T32 CA009566
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnastrozoleAntineoplastic Combined Chemotherapy ProtocolsBrain NeoplasmsBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, Intraductal, NoninfiltratingCarmustineChemoradiotherapyCraniotomyCyclophosphamideDecanoic AcidsDisease-Free SurvivalDoxorubicinFemaleHumansLeuprolideAnastrozoleCarmustinecarmustine, poliferprosan 20 drug combinationCyclophosphamideDecanoic AcidsDoxorubicinLeuprolideNitrilesPaclitaxelPolyestersReceptors, EstrogenTriazolesBrain metastases in breast cancerHormone receptor–positive breast cancerOligometastatic brain metastasesTreatment options for brain metastases in breast cancerYoung patients with breast cancer

Identifiers

PMID26943988
PMCPMC5800870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.